Below are the most recent publications written about "HTLV-I Antigens" by people in Profiles.
-
Nose H, Kubota R, Seth NP, Goon PK, Tanaka Y, Izumo S, Usuku K, Ohara Y, Wucherpfennig KW, Bangham CR, Osame M, Saito M. Ex vivo analysis of human T lymphotropic virus type 1-specific CD4+ cells by use of a major histocompatibility complex class II tetramer composed of a neurological disease-susceptibility allele and its immunodominant peptide. J Infect Dis. 2007 Dec 15; 196(12):1761-72.
-
Copeland KF, Haaksma AG, Goudsmit J, Heeney JL. Calcium-mediated inhibition of phorbol ester and Tax trans-activation of the human T cell leukaemia virus type 1. J Gen Virol. 1994 Jul; 75 ( Pt 7):1623-31.
-
Koralnik IJ, Fullen J, Franchini G. The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. J Virol. 1993 Apr; 67(4):2360-6.
-
Zhang XQ, Yang L, Ho DD, Kuritzkes DR, Chen IS, Ching WT, Chen YM, Schooley RT. Human T lymphotropic virus types I- and II-specific antibody-dependent cellular cytotoxicity: strain specificity and epitope mapping. J Infect Dis. 1992 May; 165(5):805-12.
-
Okayama A, Korber B, Chen YM, Allan J, Lee TH, Shioiri S, Tachibana N, Tsuda K, Mueller N, McLane MF, et al. Unusual pattern of antibodies to human T-cell leukemia virus type-I in family members of adult T-cell leukemia patients. Blood. 1991 Dec 15; 78(12):3323-9.
-
Yokota T, Cho MJ, Tachibana N, McLane MF, Takatsuki K, Lee TH, Mueller N, Essex M. The prevalence of antibody to p42 of HTLV-I among ATLL patients in comparison with healthy carriers in Japan. Int J Cancer. 1989 Jun 15; 43(6):970-4.
-
Poteat HT, Kadison P, McGuire K, Park L, Park RE, Sodroski JG, Haseltine WA. Response of the human T-cell leukemia virus type 1 long terminal repeat to cyclic AMP. J Virol. 1989 Apr; 63(4):1604-11.